iTeos Therapeutics Statistics
Total Valuation
ITOS has a market cap or net worth of $386.95 million. The enterprise value is -$128.37 million.
Important Dates
The next estimated earnings date is Thursday, August 7, 2025, before market open.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ITOS has 38.27 million shares outstanding. The number of shares has increased by 18.24% in one year.
| Current Share Class | 38.27M |
| Shares Outstanding | 38.27M |
| Shares Change (YoY) | +18.24% |
| Shares Change (QoQ) | +0.14% |
| Owned by Insiders (%) | 0.73% |
| Owned by Institutions (%) | 80.09% |
| Float | 22.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.23 |
| Forward PS | n/a |
| PB Ratio | 0.69 |
| P/TBV Ratio | 0.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.13, with a Debt / Equity ratio of 0.01.
| Current Ratio | 14.13 |
| Quick Ratio | 13.78 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -23.68% and return on invested capital (ROIC) is -16.80%.
| Return on Equity (ROE) | -23.68% |
| Return on Assets (ROA) | -14.54% |
| Return on Invested Capital (ROIC) | -16.80% |
| Return on Capital Employed (ROCE) | -24.14% |
| Revenue Per Employee | $202,312 |
| Profits Per Employee | -$756,133 |
| Employee Count | 173 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ITOS has paid $12.96 million in taxes.
| Income Tax | 12.96M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.69% in the last 52 weeks. The beta is 1.51, so ITOS's price volatility has been higher than the market average.
| Beta (5Y) | 1.51 |
| 52-Week Price Change | -31.69% |
| 50-Day Moving Average | 8.22 |
| 200-Day Moving Average | 8.44 |
| Relative Strength Index (RSI) | 68.07 |
| Average Volume (20 Days) | 1,750,446 |
Short Selling Information
The latest short interest is 2.53 million, so 6.62% of the outstanding shares have been sold short.
| Short Interest | 2.53M |
| Short Previous Month | 2.74M |
| Short % of Shares Out | 6.62% |
| Short % of Float | 11.47% |
| Short Ratio (days to cover) | 1.02 |
Income Statement
In the last 12 months, ITOS had revenue of $35.00 million and -$130.81 million in losses. Loss per share was -$3.09.
| Revenue | 35.00M |
| Gross Profit | 35.00M |
| Operating Income | -149.91M |
| Pretax Income | -102.48M |
| Net Income | -130.81M |
| EBITDA | -148.65M |
| EBIT | -149.91M |
| Loss Per Share | -$3.09 |
Full Income StatementBalance Sheet
The company has $520.37 million in cash and $5.05 million in debt, giving a net cash position of $515.32 million or $13.46 per share.
| Cash & Cash Equivalents | 520.37M |
| Total Debt | 5.05M |
| Net Cash | 515.32M |
| Net Cash Per Share | $13.46 |
| Equity (Book Value) | 563.42M |
| Book Value Per Share | 14.72 |
| Working Capital | 499.05M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$99.55 million and capital expenditures -$789,000, giving a free cash flow of -$100.33 million.
| Operating Cash Flow | -99.55M |
| Capital Expenditures | -789,000 |
| Free Cash Flow | -100.33M |
| FCF Per Share | -$2.62 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -428.31% |
| Pretax Margin | -336.72% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ITOS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -18.24% |
| Shareholder Yield | -18.24% |
| Earnings Yield | -33.81% |
| FCF Yield | -25.93% |
Analyst Forecast
The average price target for ITOS is $10.60, which is 4.85% higher than the current price. The consensus rating is "Hold".
| Price Target | $10.60 |
| Price Target Difference | 4.85% |
| Analyst Consensus | Hold |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -3.82% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ITOS has an Altman Z-Score of 2.76 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.76 |
| Piotroski F-Score | 2 |